Abstract: The present invention relates to the compound of formula (I), and a stereoisomer, a tautomer, a stable isotopic variation, a pharmaceutically acceptable salt or a solvate thereof, a pharmaceutical composition containing the compound, a method for using the compound for treating or preventing an ROR?-related disease, and use of the compound in the preparation of a drug for treating or preventing the ROR?-related disease.
Type:
Application
Filed:
May 14, 2021
Publication date:
June 22, 2023
Applicant:
SHANGHAI LITEDD CO., LTD.
Inventors:
Yaobang CHENG, Yafei HUANG, Juan ZHOU, Zhiqiang DONG